608 related articles for article (PubMed ID: 12177271)
1. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis.
Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2001 Dec; 83(12):1789-97. PubMed ID: 11741056
[TBL] [Abstract][Full Text] [Related]
5. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
[TBL] [Abstract][Full Text] [Related]
6. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.
Zhang T; Yu H; Gong W; Zhang L; Jia T; Wooley PH; Yang SY
Biomaterials; 2009 Oct; 30(30):6102-8. PubMed ID: 19665222
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
8. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.
Carmody EE; Schwarz EM; Puzas JE; Rosier RN; O'Keefe RJ
Arthritis Rheum; 2002 May; 46(5):1298-308. PubMed ID: 12115237
[TBL] [Abstract][Full Text] [Related]
9. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
10. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis.
Schwarz EM; Benz EB; Lu AP; Goater JJ; Mollano AV; Rosier RN; Puzas JE; Okeefe RJ
J Orthop Res; 2000 Nov; 18(6):849-55. PubMed ID: 11192243
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT.
Tsutsumi R; Hock C; Bechtold CD; Proulx ST; Bukata SV; Ito H; Awad HA; Nakamura T; O'Keefe RJ; Schwarz EM
J Orthop Res; 2008 Oct; 26(10):1340-6. PubMed ID: 18404739
[TBL] [Abstract][Full Text] [Related]
13. TNF-α suppression and osteoprotegerin overexpression inhibits wear debris-induced inflammation and osteoclastogenesis in vitro.
Peng L; Zhang H; Zhou Y; Li W; Jiang P; Zhang Y; Song K
Int J Artif Organs; 2015 Oct; 38(10):565-71. PubMed ID: 26541276
[TBL] [Abstract][Full Text] [Related]
14. Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts.
Doran PM; Turner RT; Chen D; Facteau SM; Ludvigson JM; Khosla S; Riggs BL; Russell SJ
Exp Hematol; 2004 Apr; 32(4):351-9. PubMed ID: 15050745
[TBL] [Abstract][Full Text] [Related]
15. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
[TBL] [Abstract][Full Text] [Related]
16. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.
Childs LM; Paschalis EP; Xing L; Dougall WC; Anderson D; Boskey AL; Puzas JE; Rosier RN; O'Keefe RJ; Boyce BF; Schwarz EM
J Bone Miner Res; 2002 Feb; 17(2):192-9. PubMed ID: 11811549
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
[TBL] [Abstract][Full Text] [Related]
18. Spinal implant debris-induced osteolysis.
Hallab NJ; Cunningham BW; Jacobs JJ
Spine (Phila Pa 1976); 2003 Oct; 28(20):S125-38. PubMed ID: 14560184
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of etanercept for wear debris-induced osteolysis.
Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Feb; 16(2):338-47. PubMed ID: 11204434
[TBL] [Abstract][Full Text] [Related]
20. Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model.
Zhang L; Jia TH; Chong AC; Bai L; Yu H; Gong W; Wooley PH; Yang SY
Gene Ther; 2010 Oct; 17(10):1262-9. PubMed ID: 20428210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
